Portfolio expansion in biopharmaceuticals
29 Oct 2018 | Roquette
NutritionInsight spoke with Kelsey Achenbach of Roquette at CPhI 2018 in Madrid about the company's portfolio expansion in biopharmaceuticals. This year, Roquette’s featured products included the newly launched low endotoxin Kleptose BioPharma HPB/HP grades of hydroxypropyl β-cyclodextrins for protein stability, as well as Dextrose Anhydrous BioPharma for cell culture solutions.
More videos